FDA Adverse Event Injury Summary report: N

INFINION CX

MDR report key: 12930261 · Received December 3, 2021

Report

Report Number
3006630150-2021-06939
Event Type
Injury
Date Received
December 3, 2021
Date of Event
August 27, 2021
Report Date
December 3, 2021
Manufacturer
BOSTON SCIENTIFIC NEUROMODULATION
Product Code
LGW
UDI-DI
08714729861614
PMA / PMN Number
P030017
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
NE, US
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

ADDITIONAL SUSPECT MEDICAL DEVICE COMPONENT INVOLVED IN THE EVENT:PRODUCT FAMILY: SCS-LINEAR LEAD,UPN: M365SC2317500,MODEL: SC-2317-50,SERIAL: (B)(4),BATCH: 7070966.

Description of Event or Problem · 0

IT WAS REPORTED THAT THE PATIENT WAS EXPERIENCING INADEQUATE STIMULATION DESPITE REPROGRAMMING DUE TO INCREASED PAIN. THE PATIENT WAS ALSO HAVING STIMULATION ON NON TARGETED AREAS. THE PATIENT UNDERWENT A REVISION PROCEDURE WHEREIN THE LEADS WERE REPOSITIONED. THE PATIENT WAS DOING WELL POSTOPERATIVELY.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1820753 INFINION CX STIMULATOR, SPINAL-CORD, TOTALLY IMPLANTED FOR PAIN RELIEF LGW BOSTON SCIENTIFIC NEUROMODULATION SC-2317-50 3210604 08714729861614

Patients

Seq Age Sex Outcome Treatment
1 75 YR Male Required Intervention